Epidemiology, risk factors, social determinants of health, and current management for non-alcoholic fatty liver disease in sub-Saharan Africa-Reference-Cited by-同舟云学术

Epidemiology, risk factors, social determinants of health, and current management for non-alcoholic fatty liver disease in sub-Saharan Africa

Published:2021-12 Issue:12 Volume:6 Page:1036-1046
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Spearman C Wendy,Afihene Mary,Betiku Omolade,Bobat Bilal,Cunha Lina,Kassianides Chris,Katsidzira Leolin,Mekonnen Hailemichael D,Ocama Ponsiano,Ojo Olusegun,Paruk Imran,Tzeuton Christian,Sonderup Mark W

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference129 articles.

1. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2016

2. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention;Younossi;Nat Rev Gastroenterol Hepatol,2018

3. Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in the United States and the rest of the world;Sayiner;Clin Liver Dis,2016

4. Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach;Targher;Lancet Gastroenterol Hepatol,2021

5. The natural history of advanced fibrosis due to nonalcoholic steatohepatitis: data from the simtuzumab trials;Sanyal;Hepatology,2019

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exposure to Succinate Leads to Steatosis in Non-Obese Non-Alcoholic Fatty Liver Disease by Inhibiting AMPK/PPARα/FGF21-Dependent Fatty Acid Oxidation;Journal of Agricultural and Food Chemistry;2024-09-13

2. Food inequity and insecurity and MASLD: burden, challenges, and interventions;Nature Reviews Gastroenterology & Hepatology;2024-07-29

3. Phytonanotherapy for the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease;International Journal of Molecular Sciences;2024-05-21

4. Managing cirrhosis with limited resources: perspectives from sub-Saharan Africa;The Lancet Gastroenterology & Hepatology;2024-02

5. Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies;Frontiers in Medicine;2024-01-23